Кагоцел® - противовирусный препарат для профилактики и лечения гриппа и ОРВИ у взрослых и детей с 3-х лет

KAGOCEL To Become Official Sponsor Of The ISU World Figure Skating Championships® 2018

fig championship.png

The antiviral drug Kagocel sticks to its tradition of supporting sporting events of a global scale. No. 1 non-prescription drug in Russia, as rated by the National Pharmaceutical Rating 2017, has already acted as a sponsor at the latest ISU European Figure Skating Championships®, where our figure skaters once again proved to be among the strongest athletes in Europe, having won in the medal standings. Now, Kagocel decides to support Russian athletes in their next major competition, the ISU World Figure Skating Championships® 2018. 

From March 21 through March 25, the Italian city of Milan is going to host the ISU World Figure Skating Championships® 2018, where contestants must be skaters from the ISU (International Skating Union) member-countries. The 108th championships will gather the most talented, strong, and artistically gifted skaters of the world at the Mediolanum Forum di Assago arena, where the athletes will compete in singles and pair skating.

Like any other event of this level, the World Championships promises lots of emotion to the audience; and the Russian company Nearmedic, manufacturer of Kagocel, considers supporting such an important event a great honor. After all, to be able to climb the podium, our athletes must enjoy, among other essentials, not only the love of the audience and professional skills, but robust health.


Kagocel is an original antiviral drug developed by Russian scientists for the treatment and prevention of influenza and SARS in adults and children from three years of age. The drug is provided without a doctor's prescription, possesses a high safety profile, and features a convenient regimen.

← Back to the list